Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1926 (LINC01926) is a human long non-coding RNA (lncRNA) gene, meaning it is transcribed into RNA but not translated into a protein. It is classified as an intergenic lncRNA, as its transcript does not overlap with coding regions of the genome[1][5]. Like other lincRNAs, LINC01926 may function in the regulation of gene expression, potentially acting in *cis* or *trans* to influence genetic pathways, but its specific molecular function, interacting partners, or role in disease have not been well characterized[1][5][3]. There are currently no known drugs that target LINC01926, and no mechanistic, biomarker, or therapeutic data are available for this specific lncRNA. The current evidence does not suggest it is a therapeutic target, receptor, enzyme, or other typical druggable protein class molecule[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1926 (LINC01926).